GlassScriptPhysician profile
Scott P Sweeney
NPI 1396904306
$5,407.54
in general payments reported to CMS, 2019-2025
13 companies · $20.69 in 2025
The $20.69 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $341 · 2021: $1,800 · 2022: $362 · 2023: $1,877 · 2024: $138 · 2025: $20.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,101 · Food and Beverage: $858 · Gift: $77.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,100.70 |
| Food and Beverage | $857.88 |
| Gift | $77.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,481.14 | 2022-2023 | |
| Straumann USA LLC | $1,180.86 | 2019-2023 | |
| Align Technology, INC. | $871.96 | 2020-2025 | Invisalign, Itero Element 5d Plus Lite, Itero Element 5d Plus |
| Keystone Dental INC. | $860.72 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $298.16 | 2019-2021 | |
| Ormco Corporation | $268.76 | 2022-2023 | Spark |
| Dentsply Sirona INC | $122.26 | 2020 | |
| Nobel Biocare USA | $107.79 | 2023 | Nobelactive |
| Thommen Medical USA, LLC | $99.91 | 2022-2023 | |
| 3m Company | $35.52 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $35.16 | 2021-2024 | Arestin |
| Kulzer, LLC | $29.84 | 2021 | |
| Ultradent Products INC | $15.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.